Related content

Using Partial Area for Evaluation of Bioavailability and Bioequivalence

By Chen Mei-Ling   Davit Barbara   Lionberger Robert   Wahba Zakaria   Ahn Hae-Young   Yu Lawrence  

Pharmaceutical Research, Vol. 28, Iss. 8, 2011-08 ,pp. : 1939-1947

Springer Publishing Company

Access to resources Recommend Favorite

A New Approach for Outliers in a Bioavailability/Bioequivalence Study

By Liao Jason J. Z.  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 3, 2007-05 ,pp. : 393-405

Taylor & Francis Ltd

Access to resources Recommend Favorite

Bioequivalence Criteria for Transdermal Fentanyl Generics: Do These Need a Relook?

By Walter Carmen   Felden Lisa   Lötsch Jörn  

Clinical Pharmacokinetics, Vol. 48, Iss. 10, 2009-10 ,pp. : 625-633

Adis International

Access to resources Recommend Favorite

Bioavailability and Bioequivalence of Two Enteric-Coated Formulations of Omeprazole in Fasting and Fed Conditions

By Vaz-da-Silva Manuel   Loureiro Ana I.   Nunes Teresa   Maia Joana   Tavares Susana   Falcão Amilcar   Silveira Pedro   Almeida Luis   Soares-da-Silva Patricio  

Clinical Drug Investigation, Vol. 25, Iss. 6, 2005-01 ,pp. : 391-399

Adis International

Access to resources Recommend Favorite

Bioavailability, bioequivalence, and in vitro–in vivo correlation of oxybutynin transdermal patch in rabbits

By Khire Achyut   Vavia Pradeep  

Drug Delivery and Translational Research, Vol. 4, Iss. 2, 2014-04 ,pp. : 105-115

Springer Publishing Company

Access to resources Recommend Favorite